Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|May 24, 1995
Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptorsB Levant, D E Grigoriadis, E B De Souza
Brain Research|March 20, 1992
Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatmentB Myers, B Levant, G Bissette, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 1998
Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic studyG N Bancroft, K A Morgan, R J Flietstra, et al.
Brain Research. Molecular Brain Research|February 1, 1992
BMY 14802, a potential antipsychotic drug, increases expression of proneurotensin mRNA in the rat striatumB Levant, K M Merchant, D M Dorsa, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 21, 2008
The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptorsJ M Witkin, B Levant, A Zapata, et al.
Endocrinology|February 1, 1995
Apparent seasonal rhythms in hypothalamic neuropeptides in rats without photoperiod changesG Bissette, D Griff, M Carnes, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1988
Do sympathetic neurons coordinate cellular development in the heart and kidney? Effects of neonatal central and peripheral catecholaminergic lesions on cardiac and renal nucleic acids and proteinsT A Slotkin, B Levant, L Orband-Miller, et al.
Synapse (New York, N.Y.)|November 1, 1991
Effects of CI-943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrationsB Levant, G Bissette, M D Davis, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 18, 2013
Fish oil improves motor function, limits blood-brain barrier disruption, and reduces Mmp9 gene expression in a rat model of juvenile traumatic brain injuryK L Russell, N E J Berman, P R A Gregg, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding siteB Levant, J D Moehlenkamp, K A Morgan, et al.
Pageof 4